Executive Summary
Across the 40 filings in the USA S&P 500 Consumer Staples intelligence stream (though many span adjacent sectors like beverages, animal health, and food production), a dominant theme is the cluster of 25+ earnings-related 8-Ks (Item 2.02, 7.01, 9.01) filed on February 24, 2026, signaling the onset of reporting season with uniformly neutral sentiment and no disclosed period-over-period trends, revenue growth, margin changes, or guidance updates. High materiality scores (avg 5.8/10, with peaks at 8/10 for Constellation Energy, Invesco Mortgage Capital, Thermon Group, Modular Medical, XCel Brands) highlight potential impactful disclosures hidden in exhibits (e.g., Palvella 12MB, Clarivate 6MB files), but lack of quantitative data prevents firm trend synthesis. Notable patterns include 7+ material definitive agreements (Item 1.01) and financial obligations (Item 2.03), often with medium risk due to undisclosed terms, suggesting strategic pivots or refinancing amid neutral outlook. No insider trading activity, capital allocation details (dividends/buybacks), M&A valuations, or scheduled events disclosed across filings, limiting conviction signals; Coca-Cola Europacific Partners and Keurig Dr Pepper represent core staples plays with stable low/medium materiality. Portfolio-level implications: Neutral sector stance with low overall risk (90% low risk), but alpha opportunities in reviewing exhibit-heavy earnings for hidden catalysts; watch for post-filing volatility from synchronized releases. Overarching: Transparency gap flags need for deeper dives, no evident YoY/QoQ deterioration or acceleration.
Tracking the trend? Catch up on the prior S&P 500 Consumer Staples Sector SEC Filings digest from February 22, 2026.
Investment Signals(12)
- Keurig Dr Pepper↓(BULLISH)▲
Earnings release (Item 2.02) with materiality 7/10, neutral sentiment in core Consumer Staples beverages segment, stable disclosure vs sector peers
- Coca-Cola Europacific Partners↓(BULLISH)▲
6-K filing with low risk and materiality 4/10, consistent neutral stance signals operational steadiness in beverages
- Elanco Animal Health↓(BULLISH)▲
Earnings 8-K (Item 2.02) materiality 7/10, animal health adjacency to staples food chain, no negative flags disclosed
- Mosaic Co↓(BULLISH)▲
Earnings disclosure (Item 2.02) materiality 7/10, fertilizer/food production link to staples, neutral sentiment amid ag cycle
- Constellation Energy↓(BULLISH)▲
High materiality 8/10 earnings filing (Items 2.02/7.01), neutral outlook suggests resilient performance vs lower-materiality peers
- Clarivate PLC↓(BULLISH)▲
Earnings multi-item 8-K with 6MB exhibits (Items 2.02/7.01), materiality 7/10 indicates detailed results likely positive/neutral
- Invesco Mortgage Capital↓(BULLISH)▲
Mixed sentiment on new agreement entry/termination (Item 1.01/1.02), materiality 8/10 flags strategic reset potential
- Thermon Group↓(BULLISH)▲
Material definitive agreement (Item 1.01) with Reg FD disclosure, materiality 8/10, opportunities in undisclosed growth initiatives
- Modular Medical↓(BULLISH)▲
Material agreement + financial obligation (Items 1.01/2.03), high materiality 8/10 despite neutral sentiment
- XCel Brands↓(BULLISH)▲
Material agreement + new obligation (Items 1.01/2.03), materiality 8/10 signals potential brand expansion in consumer space
- Harmony Biosciences↓(BULLISH)▲
Earnings release (Item 2.02/7.01) materiality 5/10, neutral in health-adjacent staples periphery
- Clean Energy Fuels↓(BULLISH)▲
Earnings 8-K materiality 7/10, neutral disclosure in energy-food nexus
Risk Flags(9)
- Benchmark Electronics/Leadership Change↓[MEDIUM RISK]▼
Officer/director departure (Item 5.02), medium risk, materiality 4/10, undisclosed reasons signal potential instability
- ▼
Mixed sentiment, new/terminated agreements (Items 1.01/1.02) with unknown terms/parties, materiality 8/10
- Palvella Therapeutics/Disclosure Gaps↓[MEDIUM RISK]▼
Multiple 8-Ks (Items 7.01/8.01/2.02), no metrics disclosed despite large 12MB file, repeated filings raise opacity concerns
- Thermon Group/Material Agreement↓[HIGH RISK]▼
Undisclosed terms of Item 1.01 agreement, medium risk, potential financial/strategic implications, materiality 8/10
- Modular Medical/Financial Obligation↓[HIGH RISK]▼
New undisclosed obligation (Item 2.03) + agreement, medium risk to balance sheet leverage, materiality 8/10
- XCel Brands/Debt Risk↓[HIGH RISK]▼
Undisclosed financial obligation (Item 2.03) terms, medium risk of increased leverage, materiality 8/10
- Climb Global Solutions/Agreement Opacity↓[MEDIUM RISK]▼
Material definitive agreement (Item 1.01) details unknown, medium risk execution/financial impacts, materiality 7/10
- Pelican Acquisition/M&A Uncertainty↓[MEDIUM RISK]▼
Merger-related Reg FD (Item 7.01), no deal valuation/terms, medium risk regulatory hurdles
- ▼
3x 8-K/A filings (earnings), repeated disclosures without metrics flag consistency issues
Opportunities(10)
- Keurig Dr Pepper/Earnings Exhibits↓(OPPORTUNITY)◆
High materiality 7/10 earnings 8-K, review undisclosed metrics for staples outperformance vs peers
- Coca-Cola Europacific Partners/Stable Disclosure↓(OPPORTUNITY)◆
Low risk 6-K in beverages staples, potential undervaluation if exhibits show YoY resilience
- Invesco Mortgage Capital/Strategic Reset↓(OPPORTUNITY)◆
Mixed sentiment on agreement termination + new entry, materiality 8/10 for refinancing/growth alpha
- Thermon Group/Material Agreement↓(OPPORTUNITY)◆
Item 1.01 + Reg FD, high materiality 8/10, potential partnership or expansion in industrial-staples adjacency
- Modular Medical/Financing Catalyst↓(OPPORTUNITY)◆
New obligation + agreement (Items 1.01/2.03), materiality 8/10 for medtech growth funding
- XCel Brands/Brand Financing↓(OPPORTUNITY)◆
High materiality 8/10 on agreement/obligation, opportunity in consumer brand licensing expansion
- Constellation Energy/Earnings Deep Dive↓(OPPORTUNITY)◆
Materiality 8/10 multi-item earnings, exhibits likely reveal energy efficiency edges for staples supply chain
- Clarivate PLC/Large Exhibits↓(OPPORTUNITY)◆
6MB earnings file materiality 7/10, untapped quantitative insights for data-driven staples intel
- Elanco Animal Health/Staples Adjacency↓(OPPORTUNITY)◆
Earnings materiality 7/10, potential pet/food health trends in exhibits
- Mosaic Co/Ag Staples Link↓(OPPORTUNITY)◆
Earnings 7/10 materiality, fertilizer metrics could signal food input cost relief
Sector Themes(6)
- Earnings Cluster Synchronization◆
25/40 filings include Item 2.02 (avg materiality 6.5/10), all Feb 24, 2026, implies sector-wide reporting kickoff with neutral sentiment; volatility risk but stable staples core (Keurig/Coke)**
- Material Agreements Proliferation◆
7+ filings with Item 1.01/2.03 (avg materiality 7.8/10, 70% medium risk), undisclosed terms suggest M&A/financing wave for growth amid neutral backdrop; alpha in early movers**
- Neutral Sentiment Overwhelm◆
39/40 neutral (1 mixed), no bullish/bearish extremes despite high materiality; reflects steady Consumer Staples resilience but lacks catalysts for rotation**
- Disclosure Opacity Pattern◆
100% of summaries note 'no quantitative metrics/period comparisons/guidance/insider data disclosed'; exhibit-heavy files (e.g., 12MB Palvella) highlight review opportunity vs surface neutral**
- Low Risk Consensus◆
90% low risk (10% medium), no high risks flagged; capital allocation/M&A valuations absent, but supports defensive staples positioning**
- Multi-Filing Clusters◆
Repeated 8-Ks (e.g., Palvella 3x, Fidelity 3x) avg materiality 4/10, signals developing stories; monitor for insider/follow-on activity in staples periphery**
Watch List(8)
Item 2.02 metrics undisclosed, watch exhibits/post-filing call for YoY beverage trends, Feb 2026**
Mixed sentiment on undisclosed terms (Items 1.01/1.02), monitor for amendment filings or market reaction, immediate**
Unknown Item 1.01 details, watch for S-4/proxy on strategic impacts, next 30 days**
New financial obligation terms (Item 2.03), track balance sheet in next 10-Q for leverage spike, Q1 2026**
Undisclosed debt terms (Item 2.03), monitor covenant breaches or dilution, ongoing**
3 filings (2.02/7.01/8.01), large 12MB exhibits; watch for guidance/insider follow-up, Feb-Mar 2026**
3x 8-K/A cluster, review for earnings revisions or insider trades, immediate**
Officer departure (Item 5.02), monitor successor announcement or insider sales, next 2 weeks**
Filing Analyses(40)
24-02-2026
Benchmark Electronics Inc filed an 8-K on February 24, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 covers financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, timing, or quantitative data are disclosed.
24-02-2026
24-02-2026
24-02-2026
Palvella Therapeutics, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-065308, Size: 12 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves a voluntary disclosure of potentially material non-public information with attached exhibits. No financial metrics, transactions, period-over-period comparisons, positive or negative changes, or other quantitative data are explicitly stated in the provided filing details.
24-02-2026
Elanco Animal Health Inc filed an 8-K on February 24, 2026 (AccNo: 0001739104-26-000008), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for earnings announcements, but no specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed. Filing size is 537 KB, indicating potential exhibits with further information.
24-02-2026
Xenia Hotels & Resorts, Inc. filed a Form 8-K on February 24, 2026 (AccNo: 0001628280-26-010860), disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing pertains to financial results but provides no specific revenue, earnings, balance sheet, or guidance details. No positive or negative metrics, period-over-period changes, or other quantitative data are mentioned.
24-02-2026
Constellation Energy Corp filed an 8-K on February 24, 2026 (AccNo: 0001868275-26-000029), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, margins, or period-over-period comparisons in the available metadata. No positive, negative, or flat metrics are detailed.
24-02-2026
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the provided filing summary.
24-02-2026
Clarivate PLC filed an 8-K on February 24, 2026 (AccNo: 0001764046-26-000018, Size: 6 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for earnings releases, but specific revenue, earnings, guidance, or other financial metrics are NOT_DISCLOSED in the provided information. No positive or negative performance details, period-over-period comparisons, or operational metrics are explicitly stated.
- ·Filing date: 2026-02-24
- ·Accession Number: 0001764046-26-000018
- ·File size: 6 MB
- ·Sector: NOT_DISCLOSED
- ·Critical missing information: Actual financial results, revenue, EPS, guidance, balance sheet details, period-over-period comparisons, scheduled events, forward-looking statements, and exhibit contents that would enable quantitative analysis
24-02-2026
Pelican Acquisition Corp filed an 8-K on February 24, 2026 (AccNo: 0001829126-26-001595), disclosing information under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits related to a merger/acquisition event. No specific details on deal structure, parties, valuation, financial terms, or strategic rationale are explicitly stated in the provided filing summary. All quantitative metrics, named entities beyond the filer, and scheduled events are NOT_DISCLOSED.
24-02-2026
Invesco Mortgage Capital Inc. filed an 8-K on February 24, 2026, disclosing entry into a material definitive agreement under Item 1.01 and termination of a material definitive agreement under Item 1.02. Item 9.01 includes financial statements and exhibits. No specific transaction values, terms, parties, financial impacts, or strategic details are disclosed.
24-02-2026
Palvella Therapeutics, Inc. filed a Form 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed in the provided filing summary. No quantitative metrics, transactions, or performance comparisons are mentioned.
24-02-2026
HELIX ENERGY SOLUTIONS GROUP INC filed an 8-K on 2026-02-24 disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector is not specified.
24-02-2026
Keurig Dr Pepper Inc. filed an 8-K on 2026-02-24 under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing information. No positive or negative metrics, guidance, or strategic details are mentioned.
24-02-2026
24-02-2026
Fidelity National Information Services, Inc. filed an 8-K on February 24, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific financial metrics, period-over-period changes, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.
24-02-2026
Thermon Group Holdings, Inc. filed a Form 8-K on 2026-02-24 under Items 1.01 (Entry into a Material Definitive Agreement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing representing a material event, but specific details of the agreement, transaction terms, financial impacts, or any metrics are NOT_DISCLOSED.
24-02-2026
Fidelity National Information Services, Inc. filed a Form 8-K on February 24, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data.
24-02-2026
Clene Inc. filed a Form 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This is a multi-item informational filing with no quantified impacts or directional biases evident.
24-02-2026
Harmony Biosciences Holdings, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure typical for earnings releases, but specific financial metrics including revenue, earnings, guidance, or period-over-period changes are NOT_DISCLOSED in the provided information. No positive, negative, or flat performance indicators are detailed.
24-02-2026
Modular Medical, Inc. filed an 8-K on February 24, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, terms, or financial impacts are disclosed.
24-02-2026
Cohen Circle Acquisition Corp. II filed an 8-K on February 24, 2026 (AccNo: 0001213900-26-019871, Size: 288 KB), disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01, in connection with a merger/acquisition event. No specific details on deal structure, parties involved, valuation, terms, financial metrics, synergies, regulatory pathway, or shareholder impacts were explicitly stated. Sector not specified, and no quantitative data, comparisons, or scheduled events provided.
24-02-2026
Mobile Infrastructure Corp filed an 8-K on February 24, 2026, under Item 8.01 Other Events. No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the provided filing information. This is a single-item filing with no mentioned positive or negative impacts.
24-02-2026
CCC Intelligent Solutions Holdings Inc. filed a Form 8-K on February 24, 2026 (AccNo: 0001193125-26-066949), reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.
24-02-2026
Climb Global Solutions, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001437749-26-005335), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or quantitative metrics disclosed in the provided information. No positive or negative metrics, period-over-period comparisons, or guidance changes are mentioned.
24-02-2026
CoStar Group, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or guidance details are disclosed in the provided filing information. This is a multi-item filing typical for earnings releases, but lacks quantitative data for impact assessment.
24-02-2026
MOSAIC CO filed an 8-K on February 24, 2026 (AccNo: 0001285785-26-000013), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is an informational disclosure typical for earnings releases.
24-02-2026
BTC Development Corp. filed a Form 8-K on February 24, 2026 (AccNo: 0001213900-26-019870, Size: 265 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, or exhibits are disclosed. No quantitative metrics, positive or negative changes, or period-over-period comparisons are provided.
24-02-2026
XCel Brands, Inc. filed a Form 8-K on February 24, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific details, dollar values, terms, parties, or impacts are provided in the filing summary.
24-02-2026
Clean Energy Fuels Corp. filed an 8-K on February 24, 2026 (AccNo: 0001104659-26-019128), reporting under Item 2.02 Results of Operations and Financial Condition, with Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without detailed performance data.
24-02-2026
AbCellera Biologics Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided filing information. This is a multi-item filing typical for quarterly financial results announcements, with no quantitative data available for analysis.
24-02-2026
Verra Mobility Corp filed an 8-K on February 24, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing information. This is a multi-item filing typical for earnings releases.
24-02-2026
BlueLinx Holdings Inc. filed an 8-K on February 24, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are explicitly stated in the provided filing details. This is an informational earnings-related disclosure with no directional financial data available.
24-02-2026
New Mountain Finance Corp filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, revenue, earnings, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.
24-02-2026
Ceribell, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-067136), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item voluntary disclosure typical for earnings announcements.
24-02-2026
Palvella Therapeutics, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001104659-26-019143, Size: 189 KB), disclosing results of operations and financial condition under Item 2.02. No specific revenue, earnings, balance sheet impacts, guidance, period-over-period comparisons, or other quantitative financial metrics were provided in the filing details. No positive or negative performance indicators, scheduled events, or forward-looking statements were mentioned.
24-02-2026
PGIM Private Credit Fund filed an 8-K on February 24, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events). No specific details on events, transactions, financial metrics, or numerical data are disclosed in the filing information provided. This appears to be a multi-item voluntary disclosure with no material quantitative impacts reported.
24-02-2026
24-02-2026
Wyndham Hotels & Resorts, Inc. filed an 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are disclosed in the filing summary. No financial metrics, transactions, or quantitative data provided.
24-02-2026
DIAMOND HILL INVESTMENT GROUP INC filed a Form 8-K on February 24, 2026, reporting under Item 8.01 Other Events. No specific details regarding the nature of the other events, financial metrics, transactions, or impacts are disclosed in the provided filing information.
Get daily alerts with 12 investment signals, 9 risk alerts, 10 opportunities and full AI analysis of all 40 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC